In Vitro and in Vivo Evaluation of Native Glucagon and Glucagon Analog (MAR-D28) during Aging: Lack of Cytotoxicity and Preservation of Hyperglycemic Effect

BACKGROUND: For automated prevention of hypoglycemia, there is a need for glucagon (or an analog) to be sufficiently stable so that it can be indwelled in a portable pump for at least 3 days. However, under some conditions, solutions of glucagon can form amyloid fibrils. Currently, the usage instruc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ward, W Kenneth, Massoud, Ryan G, Szybala, Cory J, Engle, Julia M, El Youssef, Joseph, Carroll, Julie M, Roberts, Charles T, DiMarchi, Richard D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Diabetes Technology Society 2010
Gaiak:
Symposium
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3005040/
https://ncbi.nlm.nih.gov/pubmed/21129325
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak